ARNOLD & PORTER KAYE SCHOLER LLP for ADAPTIVE BIOTECHNOLOGIES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| PETER ERIC DUYSHART New | Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015) |
| CJ MAHLER | — |
| BOBBY MCMILLIN | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Health Issues HCR
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| PETER ERIC DUYSHART New | Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015) |
| CJ MAHLER | — |
| BOBBY MCMILLIN | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.